Urology News and Research

Latest Urology News and Research

U.S. News ranks University of Texas MD Anderson as leading hospital for cancer care

For the fifth straight year, The University of Texas MD Anderson Cancer Center is the leading hospital in the nation for cancer care, according to the "Best Hospitals" survey published annually by U.S. News & World Report magazine.

21 Jul 2011

U.S. News ranks UC San Diego Health System among America's Best Hospitals for 2011-2012

UC San Diego Health System ranks #1 among San Diego's adult hospitals and among "America's Best Hospitals" according to U.S. News & World Report's "2011 - 2012 Best Hospitals" issue online at www.usnews.com/besthospitals and available on newsstands August 30.

21 Jul 2011

U.S. News ranks Ronald Reagan UCLA Medical Center among top five American hospitals

Ronald Reagan UCLA Medical Center ranks among the top five American hospitals, according to a U.S. News & World Report survey that reviewed patient-outcomes data, reputation among physicians and other care-related factors.

20 Jul 2011

U.S. News ranks NewYork-Presbyterian as sixth best hospital in the nation

NewYork-Presbyterian Hospital ranks #1 in New York and among the top six in the U.S. out of the nearly 5,000 hospitals evaluated by U.S. News Media & World Report for their 2011-12 Best Hospitals rankings.

20 Jul 2011

U.S. News recognizes U of U as No. 1 health care system in Salt Lake City metro area

University of Utah Health Care is the No. 1 health care system in the Salt Lake City metro area, according U.S. News & World Report's 2011-2012 Best Hospitals rankings.

20 Jul 2011

U.S. News & World Report ranks UT Southwestern as best hospital in Dallas-Fort Worth region

For the second year in a row, UT Southwestern Medical Center is the top-ranked hospital in the Dallas-Fort Worth region, according to U.S. News & World Report's annual ranking of the nation's best hospitals.

19 Jul 2011

Men with early-stage prostate cancer can benefit from short-term ADT, radiation therapy

Short-term hormone therapy given in combination with radiation therapy for men with early-stage prostate cancer increases their chance of living longer and not dying from the disease, compared with that of those who receive the same radiation therapy alone, according to a Radiation Therapy Oncology Group (RTOG) study published in the July 14 issue of the New England Journal of Medicine.

14 Jul 2011

Bladder cancer patients missing out on treatment and followups: Study

A new study released this Monday by UCLA's Jonsson Comprehensive Cancer Center shows a large majority of patients with high-grade non-muscle invasive bladder cancer do not receive the recommended treatment and surveillance, leaving them at higher risk for bladder cancer recurrence, progression, and death.

13 Jul 2011

Antares, Watson enter license deal to commercialize Anturol in the U.S. and Canada

Watson Pharmaceuticals, Inc. and Antares Pharma, Inc. today announced an exclusive licensing agreement for Watson to commercialize Antares' topical oxybutynin gel product in the U.S. and Canada.

11 Jul 2011

Shire files lawsuit against Watson over generic Vyvanse

Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market lisdexamfetamine dimesylate capsules. Watson's lisdexamfetamine dimesylate capsules are a generic version of Shire LLC's Vyvanse®.

8 Jul 2011

U.S. District Court rules in favor of Watson over Mucinex patent suit

Watson Pharmaceuticals, Inc. today confirmed that the United States Court of Appeals for the Federal Circuit has affirmed the United States District Court for the Southern District of Florida's February 2011 decision that Watson's generic versions of Mucinex(R), Mucinex(R) D, and Mucinex(R) DM Extended-Release products do not infringe U.S. Patent No. 6,372,252.

8 Jul 2011

Penis size linked to finger length: Study

A new South Korean study shows that the ratio of the length of a man's index finger to that of his ring finger is linked with penis size. The lower the ratio the longer the penis, say researchers. The study was published in the Asian Journal of Andrology.

7 Jul 2011

Hidden incision endoscopic technique eliminates visible scarring in kidney surgery

Surgery and all its implications can be scary, especially so for pediatric patients and their parents who dread sometimes disfiguring scars.

2 Jul 2011

Two defective genes may cause telomere elongations in cancer cells: Study

Scientists at Johns Hopkins have provided more clues to one of the least understood phenomena in some cancers: why the "ends caps" of cellular DNA, called telomeres, lengthen instead of shorten.

1 Jul 2011

Sensitivity of bladder cancer cells linked to chemotherapy and expression of miR-34a gene

Researchers at the UC Davis Cancer Center have discovered a way of sensitizing muscle-invasive bladder cancer cells so that they succumb to the toxic effects of chemotherapy. The finding adds to mounting evidence that tiny strands of RNA - called microRNA - play key roles in some of the deadliest types of cancer.

30 Jun 2011

Endo recalls two lots of Endocet Tablets

Endo Pharmaceuticals today issued a voluntary nationwide consumer level recall of Endocet (oxycodone/acetaminophen, USP) Tablets, 10 mg/325 mg 100 count bottles, NDC 60951-712-70, Lot # 402415NV and #402426NV.

27 Jun 2011

FDA accepts for filing Columbia's PROCHIEVE progesterone gel NDA

Columbia Laboratories, Inc. and Watson Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing Columbia's New Drug Application (NDA) for PROCHIEVE (progesterone gel) for the reduction of risk of preterm birth in women with short uterine cervical length in the mid-trimester of pregnancy.

27 Jun 2011

Endo's complete response for new formulation of OPANA ER NDA accepted by the FDA

Endo Pharmaceuticals announced today that it received notification from the U.S. Food and Drug Administration (FDA) that Endo's complete response to the FDA's Jan. 7, 2011 Action Letter relating to Endo's new drug application (NDA) for a new formulation of OPANA ER has been accepted.

24 Jun 2011

Health Canada grants market authorization for Sanofi-aventis Jevtana to treat prostate cancer

Sanofi-aventis announced today that Health Canada has granted market authorization for Jevtana injection in combination with prednisone for the treatment of patients with metastatic castration resistant prostate cancer, previously treated with a docetaxel-containing treatment regimen.

24 Jun 2011

Watson Pharmaceuticals expands Salt Lake City R&D and manufacturing facility

Watson Pharmaceuticals, Inc., today formally announced an approximately $44 million expansion of its Salt Lake City, Utah, Watson Laboratories, Inc. site.

23 Jun 2011

Urology News and Research

Latest Urology News and Research

U.S. News ranks University of Texas MD Anderson as leading hospital for cancer care

U.S. News ranks UC San Diego Health System among America's Best Hospitals for 2011-2012

U.S. News ranks Ronald Reagan UCLA Medical Center among top five American hospitals

U.S. News ranks NewYork-Presbyterian as sixth best hospital in the nation

U.S. News recognizes U of U as No. 1 health care system in Salt Lake City metro area

U.S. News & World Report ranks UT Southwestern as best hospital in Dallas-Fort Worth region

Men with early-stage prostate cancer can benefit from short-term ADT, radiation therapy

Bladder cancer patients missing out on treatment and followups: Study

Antares, Watson enter license deal to commercialize Anturol in the U.S. and Canada

Shire files lawsuit against Watson over generic Vyvanse

U.S. District Court rules in favor of Watson over Mucinex patent suit

Penis size linked to finger length: Study

Hidden incision endoscopic technique eliminates visible scarring in kidney surgery

Two defective genes may cause telomere elongations in cancer cells: Study

Sensitivity of bladder cancer cells linked to chemotherapy and expression of miR-34a gene

Endo recalls two lots of Endocet Tablets

FDA accepts for filing Columbia's PROCHIEVE progesterone gel NDA

Endo's complete response for new formulation of OPANA ER NDA accepted by the FDA

Health Canada grants market authorization for Sanofi-aventis Jevtana to treat prostate cancer

Watson Pharmaceuticals expands Salt Lake City R&D and manufacturing facility

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Urology News and Research

Latest Urology News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in